R&D Drug repositioning to bring forgotten assets from shelves to... A problem very rarely spoken about is the treatments that are promising, but are not developed further.
Patients Partner Content The PM Society – Giving Back The PM Society is a not-for-profit organisation with 40 years of Giving Back.
News PM Society announces new Chair for 2024 The PM Society has appointed Dom Marchant, Chief Creative Officer at OPEN Health, as Chair, to succeed co-chairs Caroline Benson of Cuttsy + Cuttsy and Colin Williams from Astellas.
News GSK pursues $10.6bn takeover of cancer biotech Nuvalent GSK is preparing for its biggest acquisition in more than 10 years, agreeing to buy cancer drug developer Nuvalent for $10.6 billion.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
